GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Issuance of Debt

Dae Hwa Pharm Co (XKRX:067080) Issuance of Debt : ₩68,225 Mil (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Issuance of Debt?

Dae Hwa Pharm Co's Issuance of Debt for the three months ended in Mar. 2024 was ₩10,081 Mil.

Dae Hwa Pharm Co's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was ₩68,225 Mil.


Dae Hwa Pharm Co Issuance of Debt Historical Data

The historical data trend for Dae Hwa Pharm Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Issuance of Debt Chart

Dae Hwa Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55,325.45 47,204.27 52,554.22 67,814.27 74,622.48

Dae Hwa Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16,478.31 14,873.82 24,746.00 18,524.35 10,081.00

Dae Hwa Pharm Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩68,225 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dae Hwa Pharm Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Dae Hwa Pharm Co (XKRX:067080) Business Description

Traded in Other Exchanges
N/A
Address
495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co (XKRX:067080) Headlines

No Headlines